Urinary bladder carcinogenesis in rodents bears numerous similarities to the diseases in humans. In rats, the process progresses through the morphologic stages of simple hyperplasia, papillary and nodular hyperplasia, papilloma, noninvasive, and invasive carcinoma. In mice, the pathogenesis can be similar or can follow a sequence of marked dysplasia with or without hyperplasia, leading to carcinoma in sirir and ultimately to high-grade invasive carcinoma. Although the papillary and nonpapillary diseases appear to be related in rodents and in humans, they are distinct morphologically, biologically, and molecularly. Numerous classes of genotoxic chemicals have been identified as bladder carcinogens in rodents, and some of these have also been identified as carcinogenic in humans, most notably, aromatic amines, nitrosamines, and cyclophosphamide. In contrast, nongenotoxic chemicals appear to be highly specific with respect to species, strain, diet, agent, dose, and mechanism. For some, it is unclear whether the results at high doses in rodents can be extrapolated to low doses or to humans, e.g., chemicals that cause bladder cancer only at high doses related to the formation of calculi. Numerous observations in rodents can assist in identifying possible mechanisms involved for these nongenotoxic chemicals and therefore can be important for a rational evaluation of human risk.Keycords. Bladder cancer; genotoxic chemicals; calculi; cell proliferation; hyperplasia URINARY BLADDER CANCER PATHOGENESIS Evidence increasingly is accumulating to support the hypothesis that transitional cell carcinoma of the urinary bladder actually represents 2 distinct, albeit related diseases (24, 44). The first type is papillary transitional cell carcinoma, which is usually low grade and noninvasive but tends to recur frequently following treatment. The second disease is the nonpapillary type that tends to be high grade and invasive, and it is frequently lethal to the patient due to local aggressiveness and/or distant metastases. In addition to differing pathogenetic processes, these 2 diseases appear to involve different molecular events (44). In animal models, these 2 diseases are similar to those in humans but tend to occur separately (9).In rats, bladder cancer is nearly always of the papillary type (9). The pathogenetic process for this disease involves the initial appearance of simple hyperplasia that may be diffuse or focal. This gradually evolves into focal areas of nodular and/or papillary hyperplasia, followed by evolution to a papilloma and ultimately to noninvasive low-grade carcinoma. In contrast to the disease in humans (9, 24), the papillary low-grade tumors eventually evolve into high-grade lesions and invasion, but they only rarely metastasize. Some other distinctions between the rat model and the human disease include the morphologic appearance of the papillomas, particularly the larger ones. In rats, these more closely resemble the inverted type of papilloma of humans rather the typical fronds of papillary trans...